We are live on ! Find out more
HHS icon

Harte-Hanks
HHS

1 hedge funds and large institutions have $1.74M invested in Harte-Hanks in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

7% less capital invested

Capital invested by funds: $1.87M → $1.74M (-$127K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
EVC
Eidelman Virant Capital
Missouri
-$721K
Name Holding Trade Value Shares
Change 		Change in
Stake
EVC
1
Eidelman Virant Capital
Missouri
$1.74M -$721K -124,313 -29%

HHS Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Harte-Hanks (HHS) for Q2 2021, worth a combined $1.74M — down 6.8% from $1.87M a quarter earlier.

Fund positioning in HHS was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Eidelman Virant Capital, cutting an estimated $721K.

  • 1 institutional investor held Harte-Hanks (HHS) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $1.74M of Harte-Hanks stock for Q2 2021, down 6.8% quarter-over-quarter.
  • 0 funds opened new Harte-Hanks positions in Q2 2021 and 0 closed out.
  • The largest Harte-Hanks seller in Q2 2021 was Eidelman Virant Capital, an estimated $721K sold.

Based on aggregated 13F filings for Q2 2021.